EXOZ
eXoZymes Inc
$
16.000
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
16.480
Open
16.480
VWAP
15.74
Vol
1.02K
Mkt Cap
134.20M
Low
15.3445
Amount
16.06K
EV/EBITDA(TTM)
--
Total Shares
8.39M
EV
129.22M
EV/OCF(TTM)
--
P/S(TTM)
--
eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
Show More
Valuation Metrics
The current forward P/E ratio for eXoZymes Inc (EXOZ.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess eXoZymes Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.21
Current PS
0.00
Overvalued PS
1.91
Undervalued PS
-1.49
Financials
Annual
Quarterly
FY2025Q3
YoY :
+56.49%
-2.52M
Operating Profit
FY2025Q3
YoY :
-100.00%
N/A
Net Income after Tax
FY2025Q3
YoY :
+35.00%
-0.27
EPS - Diluted
FY2025Q3
YoY :
+245.33%
-1.87M
Free Cash Flow
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
EXOZ News & Events
Events Timeline
2025-07-29 (ET)
2025-07-29
08:26:40
eXoZymes achieves four grams of NCT with over 99% purity
2025-06-26 (ET)
2025-06-26
16:27:35
eXoZymes announces role in $9.2M Meta-PURE initiative
2025-04-02 (ET)
2025-04-02
16:18:48
eXoZymes appoints Damien Perriman chief commercial officer
Sign Up For More Events
Sign Up For More Events
News
5.0
07-07NASDAQ.COMMonday 7/7 Insider Buying Report: EXOZ, IAF
3.5
04-21NewsfilterBringing clarity and precision to the cell-free space by introducing exozymes
5.0
04-10NewsfilterBioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
Sign Up For More News
People Also Watch
META
Meta Platforms Inc
594.250
USD
+0.87%
AMZN
Amazon.com Inc
220.690
USD
+1.63%
AAPL
Apple Inc
271.490
USD
+1.97%
MSFT
Microsoft Corp
472.120
USD
-1.32%
XOM
Exxon Mobil Corp
117.080
USD
+0.05%
ORCL
Oracle Corp
198.760
USD
-5.66%
WMT
Walmart Inc
105.320
USD
-1.67%
TSLA
Tesla Inc
391.090
USD
-1.05%
NVDA
NVIDIA Corp
178.880
USD
-0.97%
AVGO
Broadcom Inc
340.200
USD
-1.91%
FAQ
What is eXoZymes Inc (EXOZ) stock price today?
The current price of EXOZ is 16 USD — it has increased 0.63 % in the last trading day.
What is eXoZymes Inc (EXOZ)'s business?
What is the price predicton of EXOZ Stock?
What is eXoZymes Inc (EXOZ)'s revenue for the last quarter?
What is eXoZymes Inc (EXOZ)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for eXoZymes Inc (EXOZ)'s fundamentals?
How many employees does eXoZymes Inc (EXOZ). have?
